Skip to content
Screener

Gain Therapeutics GANX Q3 2025 earnings

Reported November 12, 2025 · Before market open

EPS-$0.15In line
EPS estimate-$0.15

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$33.3K
EPS estimate-$0.13

FAQ

When did Gain Therapeutics report Q3 2025 earnings?
Gain Therapeutics (GANX) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Gain Therapeutics's Q3 2025 revenue and EPS?
Gain Therapeutics reported eps of $-0.15 for Q3 2025.
Did Gain Therapeutics beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.15 by $0.00.
How did Gain Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 11.8% from $-0.17.
Where can I find Gain Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-110343) and the 10-Q periodic report (0001104659-25-110347) directly on SEC EDGAR. The filing index links above go to sec.gov.